Press "Enter" to skip to content

New patent expiration for Teva Womens drug ADDERALL 30

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Teva Womens drug ADDERALL 30

Annual Drug Patent Expirations for ADDERALL+30
Annual Drug Patent Expirations for ADDERALL+30

Adderall 30 is a drug marketed by Teva Womens and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.

The generic ingredient in ADDERALL 30 is amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. Additional details are available on the amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Teva Womens drug ADDERALL 30

New patent expiration for Teva Womens drug ADDERALL 30

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Teva Womens drug ADDERALL 30

Annual Drug Patent Expirations for ADDERALL+30
Annual Drug Patent Expirations for ADDERALL+30

Adderall 30 is a drug marketed by Teva Womens and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.

The generic ingredient in ADDERALL 30 is amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. Additional details are available on the amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Teva Womens drug ADDERALL 30
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions